Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 919989
                    [Title] => FDA probes new pancreas risks with diabetes drugs
                    [Summary] => 
The Food and Drug Administration is looking into new evidence that a group of recently approved diabetes drugs can increase the risk of pancreatitis and other problems.

                    [DatePublished] => 2013-03-15 01:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => World
                    [SectionUrl] => world
                    [URL] => 
                )

        )

)

VICTOZA AND BRISTOL-MYERS SQUIBB

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 919989
                    [Title] => FDA probes new pancreas risks with diabetes drugs
                    [Summary] => 
The Food and Drug Administration is looking into new evidence that a group of recently approved diabetes drugs can increase the risk of pancreatitis and other problems.

                    [DatePublished] => 2013-03-15 01:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => World
                    [SectionUrl] => world
                    [URL] => 
                )

        )

)

abtest

FDA probes new pancreas risks with diabetes drugs

March 15, 2013 - 1:00am

The Food and Drug Administration is looking into new evidence that a group of recently approved diabetes drugs can increase the risk of pancreatitis and other problems.

World